Orange Book product · Brand (NDA)
CASPOFUNGIN ACETATE
CASPOFUNGIN ACETATE
At a glance
Dec 30, 2016
Approved
Brand (NDA)
Application
AP
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 30, 2016
9 yr 7 mo ago
Today
Patent 9636407 expires
Listed drug product patent expiration.
Dec 21, 2032
in 6 yr 7 mo
Pharmaceutical detail
Active ingredient
CASPOFUNGIN ACETATE
Strength
70MG/VIAL
Dosage form
POWDER
Route
INTRAVENOUS
TE code
AP
Application
NDA 206110
Product number
002
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2001CANCIDASBrand (NDA)
NDA 021227 · MERCK
- 2025CASPOFUNGIN ACETATEGeneric (ANDA)
ANDA 216506 · HANGZHOU ZHONGMEI
- 2021CASPOFUNGIN ACETATEGeneric (ANDA)
ANDA 211263 · AREVA PHARMS
- 2018CASPOFUNGIN ACETATEGeneric (ANDA)
ANDA 209489 · CIPLA
- 2018CASPOFUNGIN ACETATEGeneric (ANDA)
ANDA 205923 · XELLIA PHARMS APS
- 2018CASPOFUNGIN ACETATEGeneric (ANDA)
ANDA 200833 · HENGRUI PHARMA
- 2017CASPOFUNGIN ACETATEGeneric (ANDA)
ANDA 207092 · GLAND
- 2017CASPOFUNGIN ACETATEGeneric (ANDA)
ANDA 207650 · PHARMOBEDIENT
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9636407 | Dec 21, 2032 | in 6 yr 7 mo | Product |

